Embryonal Rhabdomyosarcoma is a type of cancer that starts in the muscles. It usually happens in children, often in the head or neck area, like around the eye. This type of cancer is known to respond well to treatment, making it a treatable condition with the right medical care.
Every report comes from a Lived member, sent anonymously.
Have you tried Vincristine for Embryonal Rhabdomyosarcoma?
Embryonal rhabdomyosarcoma is a cancer that develops from cells that normally grow into skeletal muscle, the muscle that moves the body. It is the most common type of rhabdomyosarcoma, which is itself the most common soft tissue cancer in children. Most cases are found in young children, and it is somewhat more common in boys, but it also occurs in teenagers and, less often, adults. The tumor most often forms in the head and neck, including around the eye, or in the genital and urinary organs, though it can appear almost anywhere. The usual first sign is a lump or swelling that keeps growing. Other signs depend on location: a bulging eye, trouble urinating, or bleeding from the nose, throat, vagina or rectum.
In most children, no cause is found, and nothing a parent did or failed to do brings it on. Some inherited conditions raise the risk, such as Li-Fraumeni syndrome, neurofibromatosis type 1, Noonan syndrome and Beckwith-Wiedemann syndrome. Children who were unusually large at birth may also have a somewhat higher risk of the embryonal type. Having a risk factor does not mean a child will develop the cancer.
Doctors start with an examination and detailed scans of the affected area to see the tumor's size and what it touches. A biopsy, removing a sample of tissue, is needed to confirm the diagnosis. Because treatment depends on the exact type, the sample should be reviewed by a pathologist (a doctor who examines tissue under a microscope) experienced with rhabdomyosarcoma. Laboratory tests also check for a gene change, called a fusion, that marks the alveolar type, which has a less favorable outlook and needs more intensive treatment. Further tests, such as chest imaging, bone scans and bone marrow samples, look for spread. Together these results place the cancer in a low, intermediate or high risk group.
Treatment is planned by a children's cancer team and nearly always combines chemotherapy with surgery, radiation or both. Every child receives chemotherapy, because it lowers the chance the cancer will return even when the tumor seems fully removed. A common combination is vincristine, dactinomycin and cyclophosphamide, given in cycles over several months; lower-risk disease generally gets shorter, less intense treatment. Surgery removes the tumor when that can be done without serious harm to appearance or function. For tumors around the eye, and often in the vagina, doctors usually rely on chemotherapy and radiation rather than major surgery. Tumors near the testicle are usually removed with surgery first. Radiation treats tumor that remains or cannot be safely removed, using techniques designed to spare nearby healthy tissue. Because the cancer is rare, families are often offered a clinical trial.
Embryonal rhabdomyosarcoma generally has a better outlook than other types. In large North American trials, about 8 in 10 children with the embryonal type were alive five years after diagnosis, and results are best when the cancer has not spread and the tumor sits in a favorable location, such as around the eye. The outlook is less favorable when it has spread at diagnosis or comes back, and teenagers and adults have historically done less well than young children. Treatment often lasts many months, with frequent clinic visits and chemotherapy side effects, including periods of low blood counts. After treatment ends, scans continue for several years to check for recurrence. Survivors also need long-term follow-up for late effects that can appear years later, including problems with teeth, vision or digestion, fertility, learning or memory, and a higher chance of a second cancer.
Have a child seen promptly for a lump or swelling that keeps growing, a bulging eye, or ongoing trouble urinating or bleeding without a clear cause. During chemotherapy, call the care team right away for a fever of 100.5 F (38 C) or higher or chills, because infections can become life threatening when blood counts are low.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Embryonal Rhabdomyosarcoma is like, what's helped you, or ask the community a question.